This is a prospective, randomized, double-blind, placebo-controlled parallel group study
evaluating the use of PediaBerry for the treatment of hemangiomas in infants ≤ 4 months of
corrected gestation age over a 6-month treatment period. Subjects will be followed to age 18
months. A total of 44 subjects will be PediaBerry group and 22 subjects in the placebo
control group.
Phase:
Early Phase 1
Details
Lead Sponsor:
Indiana University
Collaborators:
National Institute of General Medical Sciences (NIGMS) National Institutes of Health (NIH)